Peer-influenced content. Sources you trust. No registration required. This is HCN.
Hematology Advisor
First-line treatment with IV iron dextran is the cost-effective strategy for managing IDA in women with HMB at commonly accepted willingness-to-pay thresholds.
Hematology February 2nd 2026
Healthline
“As bad as things were for me, crazy amounts of bleeding like you couldn’t imagine … my doctors told me it was normal” – illustrating the dangerous normalization of severe symptoms.
Endocrinology, Diabetes, Metabolism July 24th 2025
Human Reproduction
A pro-inflammatory diet was associated with a 15% higher likelihood of earlier menarche, even after adjusting for BMI and height.
Endocrinology, Diabetes, Metabolism June 5th 2025
UCLA Health
Secondary amenorrhea encompasses multiple etiologies from stress-induced hypothalamic dysfunction to PCOS-related anovulation, requiring comprehensive evaluation to prevent early-onset menopause and optimize reproductive outcomes.
Family Medicine/General Practice June 4th 2025
Medical News Today (MNT)
A UC Berkeley study found measurable concentrations of 16 different heavy metals, including lead and arsenic, in tampons from various brands, raising concerns about potential health implications for users.
Obstetrics & Gynecology July 23rd 2024
Advancements in von Willebrand Disease (VWD) treatments, including emicizumab and BT200 (rondoraptivon pegol), are heralding a new age of personalized care, addressing the complex needs of patients with this challenging bleeding disorder.
Hematology February 5th 2024